HPV mRNA testing in cervical cancer screening. - National Genomics Data Center (CNCB-NGDC)

Advanced Search

HPV mRNA testing in cervical cancer screening.

Paolo Giorgi Rossi, Matejka Rebolj

Author Information

Paolo Giorgi Rossi: Epidemiology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Matejka Rebolj: Cancer Prevention Group, School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College, London SE1 9RT, UK. Electronic address: matejka.rebolj@kcl.ac.uk.

PMID: 36174617 DOI: 10.1016/S1470-2045(22)00486-7

No abstract text available.

27047/Cancer Research UK

Early Detection of Cancer

Female

Humans

Papillomavirus Infections

RNA, Messenger

Uterine Cervical Neoplasms

RNA, Messenger

Letter Comment

HPV mRNA testing in cervical cancer screening - Authors' reply.[HPV testing in primary cervical cancer screening].HPV DNA Testing for Cervical Cancer Screening.HPV testing for primary cervical cancer screening.HPV testing in cervical screening.HPV testing in cervical screening.HPV testing in cervical screening.HPV testing improves cervical screening.HPV mRNA testing in cervical cancer screening: implications for low- and middle-income countries.HPV testing for cervical cancer screening in Croatia.

A feasibility study of DNA ploidy analysis, HPV, and TCT for screening of cervical cancer: A retrospective study.